Skip to content

Clinical trials

Phase 1/2 Lung Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20103
20111
20173
20191
20201
20211
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting5
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Revolution Medicines, Inc.2
Daiichi Sankyo1
Eisai Inc.1
FeRx1
Hoffmann-La Roche1
Merck Sharp & Dohme LLC1
Merrimack Pharmaceuticals1
Novartis Pharmaceuticals1
PMV Pharmaceuticals, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms14
Carcinoma, Non-Small-Cell Lung11
Neoplasms6
Bronchial Neoplasms5
Colonic Neoplasms5
Colorectal Neoplasms5
Head and Neck Neoplasms5
Lung Diseases5
Neoplasms by Site5
Respiratory Tract Diseases5

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.